EDGAR Filing Documents for 0001171843-18-007089

Form 8-K - Current report:

SEC Accession No. 0001171843-18-007089

Filing Date

2018-10-22

Accepted

2018-10-22 08:35:19

Documents

Period of Report

2018-10-18

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	f8k_102218.htm	8-K	15263
2	PRESS RELEASE	exh_991.htm	EX-99.1	7338
	Complete submission text file	0001171843-18-007089.txt		23982

Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8

Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200

Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34949 | Film No.: 181131584
SIC: 2834 Pharmaceutical Preparations